Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Michael K. Farris"'
Autor:
Ariel R. Choi, Ralph B. D’Agostino, Michael K. Farris, Mohammed Abdulhaleem, John C. Hunting, Yuezhu Wang, Margaret R. Smith, Jimmy Ruiz, Thomas W. Lycan, W. Jeffrey Petty, Christina K. Cramer, Stephen B. Tatter, Adrian W. Laxton, Jaclyn J. White, Wencheng Li, Jing Su, Christopher Whitlow, Fei Xing, Michael D. Chan
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Purpose/objective(s)Biomarkers for extracranial oligometastatic disease remain elusive and few studies have attempted to correlate genomic data to the presence of true oligometastatic disease.MethodsPatients with non-small cell lung cancer (NSCLC) an
Externí odkaz:
https://doaj.org/article/6364785a593e426591cfe97e0776e128
Autor:
Mohammed Abdulhaleem, John C. Hunting, Yuezhu Wang, Margaret R. Smith, Ralph D’ jr. Agostino, Thomas Lycan, Michael K. Farris, James Ververs, Hui-Wen Lo, Kounosuke Watabe, Umit Topaloglu, Wencheng Li, Christopher Whitlow, Jing Su, Ge Wang, Michael D. Chan, Fei Xing, Jimmy Ruiz
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundClinical biomarkers for brain metastases remain elusive. Increased availability of genomic profiling has brought discovery of these biomarkers to the forefront of research interests.MethodIn this single institution retrospective series, 130
Externí odkaz:
https://doaj.org/article/ea2e372464c0408ca60fc0ce7c70343a
Autor:
Cole Steber, MD, Joshua Farris, MD, PhD, Ryan T. Hughes, MD, Corbin A. Helis, MD, Tawfeq Naal, MD, Jung W. Kim-Shapiro, MD, Travis Jacobson, PhD, Michael K. Farris, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100562- (2021)
Externí odkaz:
https://doaj.org/article/10d03217cbdd46b2b19f02af05cb8c96
Autor:
Joshua C. Farris, Adam G. Johnson, Patrick P. Carriere, Zachary A. Patel, Moeko Nagatsuka, Michael K. Farris, Ryan T. Hughes
Publikováno v:
J Palliat Med
PURPOSE: To describe a novel metric to aid clinical decision making between shorter versus longer palliative radiotherapy (PRT) regimens using objective patient factors. MATERIALS AND METHODS: Patients receiving PRT at a single institution between 20
Autor:
Ryan T, Hughes, Karen E, Tye, James D, Ververs, Nathaniel S, O'Connell, Corbin A, Helis, Cole R, Steber, Adam G, Johnson, Michael D, Chan, Michael K, Farris
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 113:727-731
Autor:
Michael K. Farris, Niema B. Razavian, Ryan T. Hughes, James D. Ververs, Anna C. Snavely, Charles M. Leyrer, Karen E. Tye, Laura F. Allen, Heather D Pacholke, Kathryn E. Weaver, Paul M. Bunch, Michael D. Chan, Hollins Clark, Gregory Puthoff, Joshua C. Farris, Cole R. Steber, Stacy Wentworth, Beverly J. Levine, Chandylen L. Nightingale, Janardhana Ponnatapura
Publikováno v:
Academic Radiology.
Autor:
Joshua C. Farris, Ryan T. Hughes, Niema B. Razavian, Jane B. Pearce, Anna C. Snavely, Michael D. Chan, Cole R. Steber, C. Marc Leyrer, Paul M. Bunch, Jeffrey S. Willey, Michael K. Farris
Publikováno v:
Advances in Radiation Oncology. 8:101058
Autor:
Ryan T, Hughes, Michael H, Soike, Surendra, Prajapati, Andrew Q, Lin, James D, Ververs, Adrianna H, Masters, Corbin A, Helis, A William, Blackstock, Michael K, Farris
Publikováno v:
Journal of radiosurgery and SBRT. 6(2)
Splenic metastases from oligometastatic ovarian carcinoma are a rare occurrence. Usual treatment for splenic metastases includes splenectomy, but some patients are either unable or unwilling to undergo surgery. Stereotactic body radiotherapy (SBRT) i